Dr Amanda Hayes
Research Theme Leader
Amanda is an in vitro toxicologist who has worked in industry and academia including: Blackmores, James Cook University and The University of New South Wales (UNSW). Recently, Amanda has worked as a Regulatory Associate with Accord Australasia (peak national industry body representing manufacturers and suppliers of hygiene, cosmetic and specialty products) and Johnson and Johnson, Consumer Health (Neutrogena), supporting scientific assessment and regulatory requirements impacting industry products and operations. She has worked with the OECD as an external reviewer for their newly developed AOP’s (Adverse Outcome Pathways) of disease. Amanda managed a Chemical Safety and Applied Toxicology Laboratory and was a Senior Lecturer at the School of Risk and Safety Sciences, UNSW. Her research interests include: the percutaneous absorption of therapeutics/cosmetics using human skin in vitro, and the inhalation of nanoparticles and air toxicants using human lung cells. Amanda and colleagues (Dr Shahnaz Bakand and Prof Chris Winder) were awarded an Australian Museum Eureka Prize for pioneering research for inhalation toxicology.
Her qualifications include a PhD in the area of: Efficacy, Chemistry and Toxicology of Australian Essential Oils (UNSW, supported by Blackmores), Masters of Environmental Studies, Bachelor of Applied Science (1st class Hons: Chemistry/Microbiology) and a Graduate Cert. in Tertiary Teaching.
Amanda leads NSSN's Medtech research theme.